184 related articles for article (PubMed ID: 8782176)
1. Capillary leakage of a macromolecular MRI agent, carboxymethyldextran-Gd-DTPA, in the liver: pharmacokinetics and imaging implications.
Siauve N; Clément O; Cuénod CA; Benderbous S; Frija G
Magn Reson Imaging; 1996; 14(4):381-90. PubMed ID: 8782176
[TBL] [Abstract][Full Text] [Related]
2. Carboxymethyl-dextran-gadolinium-DTPA as a blood-pool contrast agent for magnetic resonance angiography. Experimental study in rabbits.
Loubeyre P; Canet E; Zhao S; Benderbous S; Amiel M; Revel D
Invest Radiol; 1996 May; 31(5):288-93. PubMed ID: 8724128
[TBL] [Abstract][Full Text] [Related]
3. The rete mirabile of the eel: a useful model for the study of transcapillary passage of MR contrast agents.
Siauve N; Cuénod CA; Clément O; Rasio E; Bendayan M; Frija G
J Magn Reson Imaging; 1999 Feb; 9(2):353-61. PubMed ID: 10077037
[TBL] [Abstract][Full Text] [Related]
4. Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns.
Vexler VS; Clément O; Schmitt-Willich H; Brasch RC
J Magn Reson Imaging; 1994; 4(3):381-8. PubMed ID: 8061437
[TBL] [Abstract][Full Text] [Related]
5. Hepatic kinetics and magnetic resonance imaging of gadolinium-EOB-DTPA in dogs.
Benness G; Khangure M; Morris I; Warwick A; Burrows P; Vogler H; Weinmann HJ
Invest Radiol; 1996 Apr; 31(4):211-7. PubMed ID: 8721960
[TBL] [Abstract][Full Text] [Related]
6. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging.
Hamm B; Staks T; Mühler A; Bollow M; Taupitz M; Frenzel T; Wolf KJ; Weinmann HJ; Lange L
Radiology; 1995 Jun; 195(3):785-92. PubMed ID: 7754011
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro evaluation of Gd-DTPA-polylysine as a macromolecular contrast agent for magnetic resonance imaging.
Schuhmann-Giampieri G; Schmitt-Willich H; Frenzel T; Press WR; Weinmann HJ
Invest Radiol; 1991 Nov; 26(11):969-74. PubMed ID: 1743920
[TBL] [Abstract][Full Text] [Related]
8. Gd-DTPA-cascade-polymer: potential blood pool contrast agent for MR imaging.
Adam G; Neuerburg J; Spüntrup E; Mühler A; Scherer K; Günther RW
J Magn Reson Imaging; 1994; 4(3):462-6. PubMed ID: 8061448
[TBL] [Abstract][Full Text] [Related]
9. Hepatic kinetics and magnetic resonance imaging of gadolinium ethoxybenzyl diethylenetriaminepentacetic acid (Gd-EOB-DTPA) in dogs.
Benness G; Khangure M; Morris I; Warwick A; Burrows P
Australas Radiol; 1993 Aug; 37(3):252-5. PubMed ID: 8373327
[TBL] [Abstract][Full Text] [Related]
10. Quantification of liver capillary permeability using a macromolecular contrast agent for magnetic resonance imaging.
Clément O; Vuillemin-Bodaghi V; Cuénod CA; Siauve N; Blustajn J; Frija G
Acad Radiol; 1996 Aug; 3 Suppl 2():S342-3. PubMed ID: 8796598
[No Abstract] [Full Text] [Related]
11. Comparative transmetallation kinetics and thermodynamic stability of gadolinium-DTPA bis-glucosamide and other magnetic resonance imaging contrast media.
Puttagunta NR; Gibby WA; Puttagunta VL
Invest Radiol; 1996 Oct; 31(10):619-24. PubMed ID: 8889650
[TBL] [Abstract][Full Text] [Related]
12. The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat.
Shuter B; Tofts PS; Wang SC; Pope JM
Magn Reson Imaging; 1996; 14(3):243-53. PubMed ID: 8725190
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H
Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Gd-BOPTA with Gd-DTPA in MR imaging of rat liver.
Pavone P; Patrizio G; Buoni C; Tettamanti E; Passariello R; Musu C; Tirone P; Felder E
Radiology; 1990 Jul; 176(1):61-4. PubMed ID: 2353112
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, biodistribution and contrast enhanced MR blood pool imaging of Gd-DTPA cystine copolymers and Gd-DTPA cystine diethyl ester copolymers in a rat model.
Feng Y; Zong Y; Ke T; Jeong EK; Parker DL; Lu ZR
Pharm Res; 2006 Aug; 23(8):1736-42. PubMed ID: 16850267
[TBL] [Abstract][Full Text] [Related]
17. Approximation of arterial input curve data in MRI estimation of cerebral blood-tumor-barrier leakage: comparison between Gd-DTPA and 99mTc-DTPA input curves.
Andersen C; Taagehøj JF; Mühler A; Rehling M
Magn Reson Imaging; 1996; 14(3):235-41. PubMed ID: 8725189
[TBL] [Abstract][Full Text] [Related]
18. Biliary excretion and pharmacokinetics of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging in the rat.
Schuhmann-Giampieri G; Schmitt-Willich H; Frenzel T; Schitt-Willich H [corrected to Schmitt-Willich H]
J Pharm Sci; 1993 Aug; 82(8):799-803. PubMed ID: 8377117
[TBL] [Abstract][Full Text] [Related]
19. In vivo imaging of extraction fraction of low molecular weight MR contrast agents and perfusion rate in rodent tumors.
Kovar DA; Lewis MZ; River JN; Lipton MJ; Karczmar GS
Magn Reson Med; 1997 Aug; 38(2):259-68. PubMed ID: 9256106
[TBL] [Abstract][Full Text] [Related]
20. In vivo microscopic evaluation of the microvascular behavior of FITC-labeled macromolecular MR contrast agents in the hamster skinfold chamber.
Schneider G; Seidel R; Uder M; Wagner D; Weinmann HJ; Kramann B
Invest Radiol; 2000 Sep; 35(9):564-70. PubMed ID: 10982002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
